HESA Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Minutes of Proceedings
Conservative
Bloc Québécois
NDP
The witnesses made statements and answered questions.
Luc Thériault moved, — That, in accordance with the practices governing parliamentary committee proceedings, recorded divisions be conducted in alphabetical order of Committee members and by party affiliation in the following order: Liberal Party, Conservative Party, Bloc Québécois and New Democratic Party.
Debate arose thereon.
The question was put on the motion and it was agreed to on the following recorded division:
YEAS: Dan Albas, Don Davies, Chris d'Entremont, Tom Kmiec, Larry Maguire, Luc Thériault — 6;
NAYS: Darren Fisher, Mike Kelloway, Marcus Powlowski, Sonia Sidhu, Tony Van Bynen — 5.
Don Davies moved, — That the Standing Committee on Health’s meetings on Monday, November 30, 2020; Friday, December 4, 2020; and Monday, December 7, 2020 be devoted to the Committee’s study on the Emergency Situation Facing Canadians in light of the Second Wave of the COVID-19 Pandemic.
That the Committee’s meeting on Friday, December 11, 2020 be devoted to the Committee’s study on the Patented Medicine Prices Review Board’s Guidelines.
That, pursuant to the motion adopted by the Committee on Monday, November 16, 2020, the first four meetings of the Committee’s study on the Emergency Situation Facing Canadians in light of the Second Wave of the COVID-19 Pandemic be devoted to the mental health impacts of COVID-19 based on the topic priorities submitted by parties represented on the Committee and the rotation order established by the motion.
That Members must submit potential witnesses for the Committee’s three meetings on the mental health impacts of COVID-19 no later than end of day Wednesday, November 25, 2020.
That Members must submit potential witnesses for the Committee’s study on the Patented Medicine Prices Review Board’s Guidelines no later than end of day Friday, November 27, 2020.
That each party represented on the Committee will be entitled to select one witness per meeting for the Committee’s study on the Patented Medicine Prices Review Board’s Guidelines.
That all witnesses appearing in relation to the Committee’s study on the Patented Medicine Prices Review Board’s Guidelines be required to submit a standard written declaration of potential conflicts of interest prepared by the Committee’s analysts and provided to witnesses by the Clerk prior to their appearance before the Committee, and declare any sources of funding from the pharmaceutical industry prior to testifying before Committee.
Debate arose thereon.
Luc Thériault moved, — That the motion be amended by replacing the words “Emergency Situation Facing Canadians in light of the Second Wave of the COVID-19 Pandemic” with the words “Patented Medicine Prices Review Board’s Guidelines”.
Debate arose thereon.
The question was put on the motion and it was negatived on the following recorded division:
YEAS: Luc Thériault — 1;
NAYS: Don Davies, Darren Fisher, Mike Kelloway, Marcus Powlowski, Sonia Sidhu, Tony Van Bynen — 6.
Sonia Sidhu moved, — That the motion be amended by replacing the words “four meetings on” with the words “three meetings on”.
Debate arose thereon.
The question was put on the amendment of Sonia Sidhu and it was agreed to on the following recorded division:
YEAS: Don Davies, Darren Fisher, Mike Kelloway, Marcus Powlowski, Sonia Sidhu, Tony Van Bynen — 6;
NAYS: John Barlow, Chris d'Entremont, Tom Kmiec, Larry Maguire, Luc Thériault — 5.
John Barlow moved, — That the motion be amended by adding after the words “on the Emergency Situation Facing Canadians in light of the Second Wave of the COVID-19 Pandemic” the following: “That one meeting be devoted to reviewing the availability and distribution of a vaccine”.
Debate arose thereon.
The question was put on the amendment of John Barlow and it was negatived on the following recorded division:
YEAS: John Barlow, Chris d'Entremont, Tom Kmiec, Larry Maguire, Luc Thériault — 5;
NAYS: Don Davies, Darren Fisher, Mike Kelloway, Marcus Powlowski, Sonia Sidhu, Tony Van Bynen — 6.
The question was put on the motion and it was agreed to on the following recorded division:
YEAS: John Barlow, Don Davies, Chris d'Entremont, Darren Fisher, Mike Kelloway, Tom Kmiec, Larry Maguire, Marcus Powlowski, Sonia Sidhu, Tony Van Bynen — 10;
NAYS: — 0.
The motion, as amended, read as follows:
That the Standing Committee on Health’s meetings on Monday, November 30, 2020; Friday, December 4, 2020; and Monday, December 7, 2020 be devoted to the Committee’s study on the Emergency Situation Facing Canadians in light of the Second Wave of the COVID-19 Pandemic.
That the Committee’s meeting on Friday, December 11, 2020 be devoted to the Committee’s study on the Patented Medicine Prices Review Board’s Guidelines.
That, pursuant to the motion adopted by the Committee on Monday, November 16, 2020, the first four meetings of the Committee’s study on the Emergency Situation Facing Canadians in light of the Second Wave of the COVID-19 Pandemic be devoted to the mental health impacts of COVID-19 based on the topic priorities submitted by parties represented on the Committee and the rotation order established by the motion.
That Members must submit potential witnesses for the Committee’s three meetings on the mental health impacts of COVID-19 no later than end of day Wednesday, November 25, 2020.
That Members must submit potential witnesses for the Committee’s study on the Patented Medicine Prices Review Board’s Guidelines no later than end of day Friday, November 27, 2020.
That each party represented on the Committee will be entitled to select one witness per meeting for the Committee’s study on the Patented Medicine Prices Review Board’s Guidelines.
That all witnesses appearing in relation to the Committee’s study on the Patented Medicine Prices Review Board’s Guidelines be required to submit a standard written declaration of potential conflicts of interest prepared by the Committee’s analysts and provided to witnesses by the Clerk prior to their appearance before the Committee, and declare any sources of funding from the pharmaceutical industry prior to testifying before Committee..
At 2:07 p.m., the committee adjourned to the call of the Chair.